Antineoplastic activity of ouabain and pyrithione zinc in acute myeloid leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antineoplastic activity of ouabain and pyrithione zinc in acute myeloid leukemia

Published:2011-11-21 Issue:30 Volume:31 Page:3536-3546
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Tailler M,Senovilla L,Lainey E,Thépot S,Métivier D,Sébert M,Baud V,Billot K,Fenaux P,Galluzzi L,Boehrer S,Kroemer G,Kepp O

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2011521.pdf

Reference34 articles.

1. Bielawski K, Winnicka K, Bielawska A . (2006). Inhibition of DNA topoisomerases I and II, and growth inhibition of breast cancer MCF-7 cells by ouabain, digoxin and proscillaridin A. Biol Pharm Bull 29: 1493–1497.

2. Boehrer S, Ades L, Braun T, Galluzzi L, Grosjean J, Fabre C et al. (2008). Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical study. Blood 111: 2170–2180.

3. Burnett A, Wetzler M, Lowenberg B . (2011). Therapeutic advances in acute myeloid leukemia. J Clin Oncol 29: 487–494.

4. Castedo M, Ferri K, Roumier T, Metivier D, Zamzami N, Kroemer G . (2002). Quantitation of mitochondrial alterations associated with apoptosis. J Immunol Methods 265: 39–47.

5. Chan G, Pilichowska M . (2007). Complete remission in a patient with acute myelogenous leukemia treated with erlotinib for non small-cell lung cancer. Blood 110: 1079–1080.

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ouabain-mediated downregulation of ALKBH5 and IGF2BP2 inhibits the malignant progression of DLBCL;Frontiers in Pharmacology;2024-08-30

2. SDCBP modulates tumor microenvironment, tumor progression and anti-PD1 efficacy in colorectal cancer;Cancer Gene Therapy;2024-03-30

3. Glycosides;Pharmacognosy;2024

4. Targeting cuproptosis by zinc pyrithione in triple-negative breast cancer;iScience;2023-11

5. Glycosides in the Treatment of Gastrointestinal Tract Cancer;Phytonutrients in the Treatment of Gastrointestinal Cancer;2023-04-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3